Expert Analysis

• 4 Tips On Expert Gatekeeping From J&J Talc Deal

  

  Johnson & Johnson's successful campaign to exclude plaintiff-side oncologist testimony about whether its talcum powder caused ovarian cancer, which prompted the recent resolution of 70,000 claims, offers lessons on how product liability defendants can reshape risk calculation by rigorously applying expert admissibility rules, say attorneys at Hollingsworth.

• Tracking Texas: When A Promissory Note Is Not A Security

  

  The Texas Business Court's recent application of the so-called family-resemblance test in Thompson v. Anchor Capital offers a useful road map for Texas business owners and lenders navigating the intersection of commercial lending and securities law and determining when promissory notes can be classified as securities, say attorneys at Greenberg Traurig.

• Series

  Playing Bid Whist Makes Me A Better Lawyer

  

  As a child, I viewed bid whist as a family tradition and a source of friendly card game competition, but as a lawyer, I see it as a tool that has helped me cultivate skills like communication, teamwork, risk assessment and composure, says Keyonn Pope at Riley Safer.

• AML Takes Center Stage In Financial Crime Enforcement

  

  Financial Crimes Enforcement Network actions, including its recent anti-money-laundering penalty against UBS, signal that companies should align sanctions and anti-corruption controls with documented risk assessments, quickly escalate and investigate red flags, and test remediation as enforcement intensifies, say attorneys at Bass Berry.

• Banks Should Stay Disciplined As OCC, FDIC Ease Oversight

  

  Despite a newly issued Office of the Comptroller of the Currency and the Federal Deposit Insurance Corp. rule that narrows the range of conduct that regulators may require institutions to remediate, prudent risk management suggests banks should still document how they arrive at their risk determinations, say attorneys at Crowell & Moring.

• Teva, Wyeth Show How Claimed Advances Shape Enablement

  

  Two recent Federal Circuit decisions involving method-of-treatment claims — Teva v. Eli Lilly and Wyeth v. AstraZeneca — reached opposite enablement outcomes from strikingly similar procedural postures, but a closer comparison of the cases reveals a three-step framework for understanding the court's reasoning, says Kendall Gurule at Polsinelli.

• Opinion

  The Time Is Right To Simplify Overlapping Broker-Dealer Regs

  

  While the U.S. Securities and Exchange Commission has made an important start to simplifying its rules, legislators should follow and expand on the commission's example by reexamining and removing the unnecessary overlap between SEC, Financial Industry Regulatory Authority and state broker-dealer regulations, says Howard Spindel at Integrated Solutions.

• Opinion

  Calif. Bill Goes Too Far In Trying To Regulate Attorney AI Use

  

  California’s first-in-the-nation act regulating how attorneys and arbitrators use generative artificial intelligence will likely soon become law, but read broadly, the provisions may dissuade lawyers from employing AI at all, thereby depriving them of key work tools, says Joshua Wurtzel at Schlam Stone.

• Series

  Fintech Regulator Outlook: 5 Lessons From Minnesota

  

  Minnesota's recent cryptocurrency kiosk ban and virtual currency custody rules hold several broad compliance lessons: Digital asset companies must map regulated activities, strengthen third-party oversight and engage regulators early to innovate responsibly, says Deputy Commissioner of Financial Institutions Mike Crow at the Minnesota Department of Commerce.

• Hims & Hers Suit Spotlights Health Data-Sharing Privacy Risks

  

  Regulators' complaint against telehealth company Hims & Hers alleging deceptive practices serves as a reminder that the privacy principles developed under consumer protection laws and predating omnibus statutes remain in force, and sensitive data governance continues to be a crucial component of compliance, say attorneys at Venable.

• 4 Paths To AI Safety Coordination Amid Antitrust Debate

  

  Frontier artificial intelligence companies have more room for collective safety work than the debate over an antitrust waiver suggests, with several existing avenues providing different degrees of protection and oversight, says Evan Miller at V&E.

• A Look At Litigation Risks From Financing The AI Buildout

  

  Artificial intelligence infrastructure financing can create gaps between accounting presentation and project-level economic exposure, and those gaps may affect management communications and how accounting experts can reconstruct the financial record when those communications become the subject of a securities dispute, says Erik Johannesson at Brattle Group.

• Resetting For Success After Corporate Litigation Loses Focus

  

  Corporate litigation that has lost strategic coherence may barrel disastrously ahead if counsel’s understanding of the matter drifts from the client’s goals, but cases can be wrenched back on track by diagnosing how facts have evolved, determining where resources are justified and deploying practical strategies for restoring discipline, says Jonathan Morris at Gordon Rees.

• How Prediction Markets Could Be Used In Securities Litigation

  

  Assuming there is enough liquidity, and insider trading concerns are properly addressed, prediction market prices could provide a valuable assessment of market consensus that adjusts faster than existing analysts' forecasts, which could be useful evidence to support securities class action claims, say analysts at Compass Lexecon.

• How Boards, Lenders Can View ABC Bankruptcy Alternative

  

  The broader adoption of the Uniform Assignment for the Benefit of Creditors Act, including Delaware's recent statute, gives boards and lenders a clearer framework for a familiar middle-market problem: companies too small to justify Chapter 11 economics but too complex for an unmanaged shutdown, says Jon Labovitz at Sherwood.